Ginkgo Bioworks Holdings (DNA) Non Operating Income (2021 - 2026)

Ginkgo Bioworks Holdings (DNA) has 6 years of Non Operating Income data on file, last reported at -$4.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 111.78% year-over-year to -$4.8 million; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (up 44.14% YoY), and the FY2025 full-year result was $1.7 million, down 86.3% from the prior year.
• Non Operating Income for Q1 2026 stood at -$4.8 million, up from -$10.6 million in the prior quarter.
• Across five years, Non Operating Income topped out at $82.6 million in Q1 2022 and bottomed at -$33.8 million in Q4 2023.
• The 5-year median for Non Operating Income is -$1.6 million (2024), against an average of $4.0 million.
• The widest annual swing landed in 2022, when Non Operating Income tumbled 552.2%; it then soared 688.5% in 2025.
• A 5-year view of Non Operating Income shows it stood at $43.0 million in 2022, then tumbled by 178.52% to -$33.8 million in 2023, then surged by 87.41% to -$4.3 million in 2024, then plunged by 150.22% to -$10.6 million in 2025, then surged by 55.22% to -$4.8 million in 2026.
• The last three Non Operating Income figures came in at -$4.8 million (Q1 2026), -$10.6 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.

Peer Comparison